Fate Therapeutics Inc (FATE) — Capital Reinvestment Ratio

Latest as of June 2020: 0.02x

Fate Therapeutics Inc (FATE) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($38.84 Million) in capital expenditures ($636.00K). Check Fate Therapeutics Inc (FATE) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$38.84 Million

USD

Capital Expenditures

$636.00K

USD

Data as of

Jun 2020

Most recent filing

Annual Capital Reinvestment Ratio for Fate Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Fate Therapeutics Inc from None to None. See how much free cash does Fate Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow